If you are having trouble viewing this email, view online version .

ESE News Alert - 24 June 2020

Cortisol may increase COVID-19 mortality risk

Higher levels of the stress hormone, cortisol, may increase the severity of COVID-19, according to a study published in The Lancet Diabetes & Endocrinology.

The Science Times

Potential obesity treatment may increase sepsis risk

According to a study published in the Proceedings of the National Academy of Sciences USA, GDF15, a hormone being investigated as an obesity treatment may promote bacterial infection of wounds and increase sepsis risk.

News Medical

New COVID-19 drug to be trialled in UK hospitals

UK hospitals are trialling a new drug, TRV027, that aims to restore the balance between the two hormones, angiotensin II and angiotensin 1-7, to help prevent blood clots and lung damage caused by COVID-19.

Science Focus

Oral contraceptives may reduce bone loss in premature ovarian sufficiency

Combined oral contraceptives may reduce bone mass loss in women with premature ovarian insufficiency, according to a study published in Menopause.

News Medical

The European Society of Endocrinology is Europe’s premier learned society promoting research, education and clinical practice in endocrinology for the public benefit and representing doctors and scientists who work in endocrinology. For more information, visit http://www.ese-hormones.org/

This news alert is designed to provide European Society of Endocrinology (ESE) members with a summary of stories on endocrinology currently appearing in the media. The views expressed in the stories featured in this update are not necessarily those of the ESE. The ESE accepts no responsibility for the accuracy or completeness of the material contained in this alert.

If you know of some European media coverage that would be of interest to the ESE membership, please contact the ESE press office.

Please note that the address that sent this email is not monitored and we cannot respond to direct replies.

Stay connected